# LifeShare Blood Centers – FDA Inspection, Nov 4, 2024

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/af587107-e663-4fa6-9374-e6757e70dff7
Source feed: FDA_Inspections

> FDA inspection 1254262 of LifeShare Blood Centers, November 04, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254262
- Company Name: LifeShare Blood Centers
- Inspection Date: 2024-11-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1098161 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/aa61dacf-f77a-45c1-86bb-a8d6299046cb)
- FDA Inspection 995056 - 2016-11-03
- FDA Inspection 900426 - 2014-10-17
- [FDA Inspection 826041 - 2013-04-05](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-centers/a3258b25-f0b2-4a6b-8a00-42055fd19815)
- FDA Inspection 730854 - 2011-06-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/michelle-paxon/1748c593-7d85-4ede-a5f4-8c0a33c21d52)

Company: https://www.keypedia.com/companies/lifeshare-blood-centers/1bdaab16-b90b-414a-b085-ec21dd9a60d6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d